Pharmacogenetics and the future of medical practice

被引:29
作者
Lindpaintner, K [1 ]
机构
[1] F Hoffmann La Roche, Roche Genet, CH-4070 Basel, Switzerland
来源
JOURNAL OF MOLECULAR MEDICINE-JMM | 2003年 / 81卷 / 03期
关键词
pharmacogenetics; pharmacogenomics; single nucleotide polymorphism; polymorphism; gene variant;
D O I
10.1007/s00109-002-0416-5
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Pharmacogenetics is today widely proclaimed to be about to revolutionize the face of medicine. In a more realistic assessment, the implementation of molecular genetics and biology will continue to provide us, as it has done already, with better ways to diagnose and treat illnesses, but it will do so at a stepwise and evolutionary pace, based on an improved understanding of the nature of disease, allowing more specific treatments, better risk prediction, and the implementation of preventive strategies. As such, future progress in biomedicine will travel the same well-trodden paths of improved differential diagnosis and risk prediction along which it has advanced in the past decades and centuries. Thus, while meaningful biomedical research today by and large depends on the use of the newly developed tools of genetics and genomics and the insights that we gain through them, it is unlikely fundamentally to change the direction of medical progress.
引用
收藏
页码:141 / 153
页数:13
相关论文
共 24 条
[11]   AMINO-TERMINAL POLYMORPHISMS OF THE HUMAN BETA(2)-ADRENERGIC RECEPTOR IMPART DISTINCT AGONIST-PROMOTED REGULATORY PROPERTIES [J].
GREEN, SA ;
TURKI, J ;
INNIS, M ;
LIGGETT, SB .
BIOCHEMISTRY, 1994, 33 (32) :9414-9419
[12]   INFLUENCE OF BETA(2)-ADRENERGIC RECEPTOR GENOTYPES ON SIGNAL-TRANSDUCTION IN HUMAN AIRWAY SMOOTH-MUSCLE CELLS [J].
GREEN, SA ;
TURKI, J ;
BEJARANO, P ;
HALL, IP ;
LIGGETT, SB .
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 1995, 13 (01) :25-33
[13]   Not quite pharmacogenomics [J].
Haseltine, WA .
NATURE BIOTECHNOLOGY, 1998, 16 (13) :1295-1295
[14]  
HUANG RD, 1996, FINANCIAL MARKETS I, V5, P1
[15]   PROPOSED MOLECULAR AND CELLULAR MECHANISM FOR AMINOGLYCOSIDE OTOTOXICITY [J].
HUTCHIN, T ;
CORTOPASSI, G .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1994, 38 (11) :2517-2520
[16]   Naturally occurring mutations in the human 5-lipoxygenase gene promoter that modify transcription factor binding and reporter gene transcription [J].
In, KH ;
Asano, K ;
Beier, D ;
Grobholz, J ;
Finn, PW ;
Silverman, EK ;
Silverman, ES ;
Collins, T ;
Fischer, AR ;
Keith, TP ;
Serino, K ;
Kim, SW ;
DeSanctis, GT ;
Yandava, C ;
Pillari, A ;
Rubin, P ;
Kemp, J ;
Israel, E ;
Busse, W ;
Ledford, D ;
Murray, JJ ;
Segal, A ;
Tinkleman, D ;
Drazen, JM .
JOURNAL OF CLINICAL INVESTIGATION, 1997, 99 (05) :1130-1137
[17]   Association between genetic polymorphisms of the β2-adrenoceptor and response to albuterol in children with and without a history of wheezing [J].
Martinez, FD ;
Graves, PE ;
Baldini, M ;
Solomon, S ;
Erickson, R .
JOURNAL OF CLINICAL INVESTIGATION, 1997, 100 (12) :3184-3188
[18]   Polymorphisms of the 5′ leader cistron of the human β2-adrenergic receptor regulate receptor expression [J].
McGraw, DW ;
Forbes, SL ;
Kramer, LA ;
Liggett, SB .
JOURNAL OF CLINICAL INVESTIGATION, 1998, 102 (11) :1927-1932
[19]   HIV-1 infection in a man homozygous for CCR5 Delta 32 [J].
OBrien, TR ;
Winkler, C ;
Dean, M ;
Nelson, JAE ;
Carrington, M ;
Michael, NL ;
White, GC .
LANCET, 1997, 349 (9060) :1219-1219
[20]   MUTATIONS IN THE GENE ENCODING FOR THE BETA-2-ADRENERGIC RECEPTOR IN NORMAL AND ASTHMATIC SUBJECTS [J].
REIHSAUS, E ;
INNIS, M ;
MACINTYRE, N ;
LIGGETT, SB .
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 1993, 8 (03) :334-339